Device-related pressure ulcers: The role of bioengineering in prevention of these injuries during the coronavirus pandemic.
- - Explain the etiology of device-related pressure ulcers/injuries (DRPIs) including DRPIs caused by personal protective equipment (PPE) in the context of the COVID-19 pandemic
- - Provide timely and relevant examples of the damage pathways caused by several medical devices which are commonly used in intensive care (including care of COVID-19 patients)
- - Describe the biomechanical principles for effective prevention of DRPIs through minimization of soft tissue exposures to sustained mechanical deformations.
- - Demonstrate use of state-of-the-art bioengineering approaches to etiological DRPI research and characterization of the DRPI risk levels associated with use of intensive care equipment, including with regards to evaluations of improvements and new medical technologies and devices
Amit Gefen, PhD
Professor Amit Gefen is a Full Professor with the Department of Biomedical Engineering at the Faculty of Engineering of Tel Aviv University and the Herbert J. Berman Chair in Vascular Bioengineering. Prof. Gefen is also the Head of the Ela Kodesz Institute for Medical Engineering and Physical Sciences at Tel Aviv University. The research interests of Prof. Gefen are in studying normal and pathological effects of biomechanical factors on the structure and function of cells, tissues and organs, with emphasis on applications in chronic wound research. In 2007-2008 he was a visiting scientist at Eindhoven University of Technology in the Netherlands, where he developed tissue-engineered model systems to study pressure ulcers. To date, Prof. Gefen published more than 250 articles in peer-reviewed international journals, many of which on mechanobiology, cell and tissue biomechanics, with applications that are mostly in chronic wound prevention. He has also edited several books.
Prof. Gefen had visiting professorship appointments and fellowships in multiple UK universities. He is the founder and chair of the conference series - Wound Care: From Innovations to Clinical Trials. His research has been funded for example by the European Commission (EC), the Israel Science Foundation, Israeli Ministry of Health, Ministry of Science, Ministry of Defense and national as well as international corporates. Prof. Gefen is advising and reviewing for the top-tier scientific journals such as the Lancet, and for funding bodies worldwide including the EC. He also serves as a scientific advisor to the global medical device industry.
By registering for this program, you consent to share your registration information with the program's sponsor.